Product Code: ETC8854052 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Vasopressin plays an essential role in treating vasoplegic shock, especially post-cardiac surgery or in septic patients. The market is relatively small but growing within advanced hospital settings. As critical care practices become more standardized and local hospitals expand their intensive care capabilities, usage of vasopressin is expected to rise.
Vasopressin is becoming a key therapeutic agent in managing vasoplegic shock, particularly in post-cardiac surgery patients and septic shock cases unresponsive to other vasopressors. With growing adoption of advanced cardiac procedures in metropolitan hospitals, use of vasopressin is rising. Clinical guidelines now support its role as a second-line agent, but its adoption is limited by its cost and the need for careful monitoring.
The market struggles with limited clinical adoption due to inconsistent medical guidelines and lack of awareness among healthcare professionals. Accessibility in rural hospitals is also a concern, given that vasopressin is often considered a secondary or backup drug.
The treatment of vasoplegic shock, particularly in post-cardiac surgery settings, is gaining importance in the Philippines. The increasing availability of advanced surgical facilities and critical care units makes this a viable market. Investment opportunities include local manufacturing or importation of vasopressin formulations and partnerships with tertiary hospitals to streamline supply chains and educational outreach.
Use of vasopressin in critical care is supported through DOHs guidelines on shock management in hospitals. It is often covered in ICU protocols and included in the procurement list for public healthcare institutions. Regulatory approval and pharmacovigilance are managed by the FDA.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Vasopressin for Vasoplegic Shock Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Vasopressin for Vasoplegic Shock Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Vasopressin for Vasoplegic Shock Market - Industry Life Cycle |
3.4 Philippines Vasopressin for Vasoplegic Shock Market - Porter's Five Forces |
3.5 Philippines Vasopressin for Vasoplegic Shock Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Vasopressin for Vasoplegic Shock Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Vasopressin for Vasoplegic Shock Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Vasopressin for Vasoplegic Shock Market Trends |
6 Philippines Vasopressin for Vasoplegic Shock Market, By Types |
6.1 Philippines Vasopressin for Vasoplegic Shock Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Vasopressin for Vasoplegic Shock Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Vasopressin for Vasoplegic Shock Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.1.4 Philippines Vasopressin for Vasoplegic Shock Market Revenues & Volume, By Intramuscular Injection, 2021- 2031F |
6.1.5 Philippines Vasopressin for Vasoplegic Shock Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F |
6.2 Philippines Vasopressin for Vasoplegic Shock Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Vasopressin for Vasoplegic Shock Market Revenues & Volume, By Sepsis, 2021- 2031F |
6.2.3 Philippines Vasopressin for Vasoplegic Shock Market Revenues & Volume, By Post Cardiac Surgery, 2021- 2031F |
6.2.4 Philippines Vasopressin for Vasoplegic Shock Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Vasopressin for Vasoplegic Shock Market Import-Export Trade Statistics |
7.1 Philippines Vasopressin for Vasoplegic Shock Market Export to Major Countries |
7.2 Philippines Vasopressin for Vasoplegic Shock Market Imports from Major Countries |
8 Philippines Vasopressin for Vasoplegic Shock Market Key Performance Indicators |
9 Philippines Vasopressin for Vasoplegic Shock Market - Opportunity Assessment |
9.1 Philippines Vasopressin for Vasoplegic Shock Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Vasopressin for Vasoplegic Shock Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Vasopressin for Vasoplegic Shock Market - Competitive Landscape |
10.1 Philippines Vasopressin for Vasoplegic Shock Market Revenue Share, By Companies, 2024 |
10.2 Philippines Vasopressin for Vasoplegic Shock Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |